Clinical Trial Update: Safety and Efficacy of 9MW2821 in the Treatment of High-risk Non-muscle-invasive Bladder Cancer (NMIBC) [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update indicating that 9MW2821 is being evaluated for safety and efficacy in high-risk non-muscle-invasive bladder cancer and is curren…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• 9MW2821

Snippet

Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Conditions: Bladder Cancer | Phase 1 | Status: RECRUITING